Morgan L. Maeder, et al. Therapeutic Correction of an LCA-Causing Splice Defect in the CEP290 Gene by CRISPR/Cas-Mediated Genome Editing. Presented at the Association for Research in Vision and Ophthalmology (ARVO), May 1-5, 2016 in Seattle, WA.

Jun

23

Editas Medicine Announces Enrollment of the First Pediatric Cohort in the BRILLIANCE Clinical Trial of EDIT-101 for the Treatment of LCA10 Following IDMC Endorsement

Jun

15

Editas Medicine Reports Inducement Grants to New Chief Scientific Officer and Chief Regulatory Officer

Jun

14

Editas Medicine Strengthens Executive Leadership Team to Advance Pipeline and Support Long-term Growth